Sort
82,697 grants matching “vaccine development”
Cell Prep Core
$1,157,471Steven Rosenberg · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination
$1,157,223Maya Mitchell · La Jolla Institute For Immunology · N01 · FY2023 · AI
DNA Vaccine for Seasonal & Pandemic Influenza
$1,157,024Deborah L. Fuller · Albany Medical College · U01 · FY2008 · AI
An Adaptive Intervention Trial of Home Testing with Behavioral Nudges for Improving COVID-19 Testing and Prevention among People Affected by Diabetes
$1,156,661Mary Beth Weber · Emory University · U01 · FY2022 · DK
Development of Chimeric Vesiculo/Alphaviruses as an Alphavirus Vaccine
$1,156,616John Rose · Yale University · R56 · FY2013 · AI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses
$1,156,549David E. Clements · Hawaii Biotech, Inc. · R44 · FY2015 · AI
Administrative Core
$1,156,287Samuel I. Miller · University Of Washington · U54 · FY2008 · AI
Role of Gut and Skin Flora in the Control of Immune Responses
$1,156,090Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Project 1
$1,155,919Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2022 · AI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
$1,155,591Rasmus Skaarup Mortensen · Statens Serum Institute · R01 · FY2021 · AI
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,155,500Mark Fredric Cotton · Stellenbosch University · UM1 · FY2015 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,155,281Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,155,012Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Pacific Center for Emerging Infectious Diseases Research
$1,155,000Richard Yanagihara · University Of Hawaii At Manoa · P30 · FY2016 · GM
DEVELOPMENT OF A RECOMBINANT LISTERIA MONOCYTOGENES BOOSTER VACCINE AGAINST TUBERCULOSIS
$1,155,000University Of California, Los Angeles · · FY2012 · Department of Defense
Pacific Center for Emerging Infectious Diseases Research
$1,155,000Richard Yanagihara · University Of Hawaii At Manoa · P30 · FY2018 · GM
Pacific Center for Emerging Infectious Diseases Research
$1,155,000Vivek Ramchandra Nerurkar · University Of Hawaii At Manoa · P30 · FY2019 · GM
Pacific Center for Emerging Infectious Diseases Research
$1,155,000Richard Yanagihara · University Of Hawaii At Manoa · P30 · FY2017 · GM
Data Analysis and Management Core
$1,154,883Raphael Gottardo · Seattle Children'S Hospital · U19 · FY2018 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,154,810University Of Alabama At Birmingham · U01 · FY2000 · AI
Virus-Like Particle Vaccines for Pandemic Influenza
$1,154,441Ted M Ross · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · AI
Durban International Clinical Trials Unit
$1,154,244Umesh G Lalloo · University Of Kwazulu-Natal · UM1 · FY2012 · AI
Task V11: General Safety Toxicity Testing
$1,154,109Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2024 · AI
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,154,104Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pediatric Clinical Research Scholar Program - Washington
$1,154,042Children'S Research Institute · K12 · FY2004 · RR